DekaBank Deutsche Girozentrale’s Indivior Pharmaceuticals INDV Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,766	Closed	-$905K	–	1231
2025 Q4	$905K	Hold	45,766	–	–	﹤0.01%	899
2025 Q3	$1.05M	Hold	45,766	–	–	﹤0.01%	861
2025 Q2	$639K	Hold	45,766	–	–	﹤0.01%	940
2025 Q1	$433K	Hold	45,766	–	–	﹤0.01%	994
2024 Q4	$556K	Hold	45,766	–	–	﹤0.01%	984
2024 Q3	$460K	Hold	45,766	–	–	﹤0.01%	1031
2024 Q2	$755K	Hold	45,766	–	–	﹤0.01%	935
2024 Q1	$985K	Hold	45,766	–	–	﹤0.01%	879
2023 Q4	$692K	Sell	45,766 -76,000	-62%	-$1.35M	﹤0.01%	969
2023 Q3	$2.63M	Sell	121,766 -9,000	-7%	-$205K	0.01%	682
2023 Q2	$2.96M	Buy	+130,766	New	+$3M	0.01%	673

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

DekaBank Deutsche Girozentrale's INDV Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Indivior Pharmaceuticals (INDV) in Q1 2026, closing a stake of 45,766 shares — an estimated $905K sold.

DekaBank Deutsche Girozentrale first reported a position in INDV in Q2 2023 and held it in 11 quarters. The position peaked at $2.96M in Q2 2023. 290 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Indivior Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 45,766 Indivior Pharmaceuticals shares in Q1 2026, an estimated $905K.
DekaBank Deutsche Girozentrale first reported a position in Indivior Pharmaceuticals in Q2 2023 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Indivior Pharmaceuticals position peaked at $2.96M in Q2 2023.
290 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.